Miles Gerson

Miles Gerson is a Partner at SV Health Investors co-leading the Dementia Discovery Fund, based in Cambridge, Massachusetts. Prior to this role, he served as Global Head and President of Takeda Ventures, where he managed corporate venture operations and oversaw an equity portfolio exceeding 60 private and public life sciences investments. During his tenure at Takeda, he also held interim responsibility as the Head of Gastrointestinal Business Development. Additionally, he serves as the Independent Chairman of the board for Integra Therapeutics and has participated on multiple limited partner advisory committees. Earlier in his career, he functioned as founding management for early-stage enterprises and directed investment diligence for various venture and private equity firms across the United States and Europe. Gerson currently focuses on advancing dementia therapeutics and executing life sciences venture investments utilizing over 15 years of industry experience.